Establishing, harmonizing and analyzing critical values in a large academic health center
-
Ibrahim A. Hashim
and
Jennifer A. Cuthbert
Abstract
Background: No report on establishing critical values (CVs) lists has described a process for harmonizing different lists in a large academic health center or validation on follow-up after 5 years.
Methods: A definition of a critical value was adopted. CVs in use and reporting times for chemistry, hematology and coagulation (CH&C) tests during a 1-week period at one hospital were analyzed prior to the revision and again 5 years later.
Results: CVs lists in use by the different campus hospital laboratories were reviewed for compliance with the definition for a critical value. Lists were harmonized with a total of 37 CH&C tests, five of these included adult and either cord blood or neonatal values. Overall, 26 tests were eliminated, 61 individual values were changed and two tests were added. The revised CVs list reduced the number of calls at one primary teaching hospital by 33%. In the next 5-year period, value thresholds changed (n=2) and one value was re-instated (n=1). When retrospectively examined for impact, one value change was considered appropriate.
Conclusions: CVs lists were harmonized among campus hospitals. Tests not considered critical were removed and values adjusted for uniformity. Changes in CVs lists should be evaluated for appropriateness. A process is now in place for periodic review and considerations related to CVs lists.
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Author contributions: Ibrahim Hashim – study design; acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the original manuscript for important intellectual content. Jennifer A. Cuthbert – study design; acquisition of data; review of clinical records; analysis and interpretation of data; drafting of the original manuscript; critical revision of the original manuscript for important intellectual content.
References
1. Lundberg GD. When to panic over abnormal values. Med Lab Obs 1972;4:47–54.Search in Google Scholar
2. Medicare, Medicaid, and CLIA Programs: laboratory requirements relating to quality systems and certain personnel qualifications. Fed Regist 2003;68:3639–714.Search in Google Scholar
3. The Joint Commission. Accreditation Program: Laboratory, National Patient Safety Goals (NPSG020301). Available from: http://www.jointcommission.org/standards_information/npsgs.aspx. Accessed 31 January, 2014.Search in Google Scholar
4. College of American Pathologists. Laboratory General Checklist [components GEN.41320, GEN.41330, and GEN.41340]. Available from: http://www.cap.org/apps/docs/pathology_reporting/LabGeneralChecklist_Reporting.pdf Accessed 31 January, 2014.Search in Google Scholar
5. Kost GJ. Critical limits for urgent clinician notification at US medical centers. J Am Med Assoc 1990;263:704–7.10.1001/jama.1990.03440050098042Search in Google Scholar
6. Kost GJ. Critical limits for emergency clinician notification at United States children′s hospitals. Pediatrics 1991;88: 597–603.10.1542/peds.88.3.597Search in Google Scholar
7. Howanitz PJ, Steindel SJ, Heard NV. Laboratory critical values policies and procedures: a college of American Pathologists Q-Probes Study in 623 institutions. Arch Pathol Lab Med 2002;126:663–9.10.5858/2002-126-0663-LCVPAPSearch in Google Scholar PubMed
8. Genzen JR, Tormey CA. Pathology consultation on reporting of critical values. Am J Clin Pathol 2011;135:505–13.10.1309/AJCP9IZT7BMBCJRSSearch in Google Scholar PubMed PubMed Central
9. Zeng R, Wang W, Wang Z. National survey on critical values notification of 599 institutions in China. Clin Chem Lab Med 2013;51:2099–107.10.1515/cclm-2013-0183Search in Google Scholar PubMed
10. Piva E, Plebani M. From “panic” to “critical” values: which path toward harmonization? Clin Chem Lab Med 2013;51: 2069–71.10.1515/cclm-2013-0459Search in Google Scholar PubMed
©2014 by Walter de Gruyter Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Colorectal cancer and screening programs: not only analytical issues
- Reviews
- Laboratory diagnostics of inherited platelet disorders
- Reticulated platelets: analytical aspects and clinical utility
- Genetics and Molecular Diagnostics
- Advanced tools for BRCA1/2 mutational screening: comparison between two methods for large genomic rearrangements (LGRs) detection
- General Clinical Chemistry and Laboratory Medicine
- Establishing, harmonizing and analyzing critical values in a large academic health center
- Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: impact on clinical populations
- First fully automated immunoassay for anti-Müllerian hormone
- A multicenter evaluation of dysthyroxinemia in a defined patient cohort
- New biomarkers in diagnosis of early onset preeclampsia and imminent delivery prognosis
- Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women
- Development of a new immunoassay for the detection of ethyl glucuronide (EtG) in meconium: validation with authentic specimens analyzed using LC-MS/MS. Preliminary results
- Optimizing centrifugation of coagulation samples in laboratory automation
- Evaluation of the automated coagulation analyzer CS-5100 and its utility in high throughput laboratories
- A new sampling device for faecal immunochemical testing: haemoglobin stability is still an open issue
- Reference Values
- Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening
- Cancer Diagnostics
- Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients
- Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium
- Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas
- Letters to the Editor
- Further comments on “Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation”
- A questionnaire study among nurses: awareness of blood and urine sample collection procedures
- Measurement uncertainty and clinical interpretation of measurement results
- Laboratory automation: how will you select the boarding assays?
- Improvement and evaluation of a 1,2-dioleoylglycerol method for measuring pancreatic lipase catalytic activity in serum
- The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family
- 1,5 Anhydroglucitol serum concentration as a biomarker for screening gestational diabetes in early pregnancy
- A rare condition: IgE type monoclonal gammopathy of undetermined significance
- Laboratory analysis of intraosseous blood: bad to the bone?
Articles in the same Issue
- Frontmatter
- Editorial
- Colorectal cancer and screening programs: not only analytical issues
- Reviews
- Laboratory diagnostics of inherited platelet disorders
- Reticulated platelets: analytical aspects and clinical utility
- Genetics and Molecular Diagnostics
- Advanced tools for BRCA1/2 mutational screening: comparison between two methods for large genomic rearrangements (LGRs) detection
- General Clinical Chemistry and Laboratory Medicine
- Establishing, harmonizing and analyzing critical values in a large academic health center
- Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: impact on clinical populations
- First fully automated immunoassay for anti-Müllerian hormone
- A multicenter evaluation of dysthyroxinemia in a defined patient cohort
- New biomarkers in diagnosis of early onset preeclampsia and imminent delivery prognosis
- Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women
- Development of a new immunoassay for the detection of ethyl glucuronide (EtG) in meconium: validation with authentic specimens analyzed using LC-MS/MS. Preliminary results
- Optimizing centrifugation of coagulation samples in laboratory automation
- Evaluation of the automated coagulation analyzer CS-5100 and its utility in high throughput laboratories
- A new sampling device for faecal immunochemical testing: haemoglobin stability is still an open issue
- Reference Values
- Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening
- Cancer Diagnostics
- Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients
- Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium
- Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas
- Letters to the Editor
- Further comments on “Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation”
- A questionnaire study among nurses: awareness of blood and urine sample collection procedures
- Measurement uncertainty and clinical interpretation of measurement results
- Laboratory automation: how will you select the boarding assays?
- Improvement and evaluation of a 1,2-dioleoylglycerol method for measuring pancreatic lipase catalytic activity in serum
- The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family
- 1,5 Anhydroglucitol serum concentration as a biomarker for screening gestational diabetes in early pregnancy
- A rare condition: IgE type monoclonal gammopathy of undetermined significance
- Laboratory analysis of intraosseous blood: bad to the bone?
